Bottom line
IEFA vs IDEV: the short answer
IEFA (iShares Core MSCI EAFE ETF) and IDEV (iShares Core MSCI International Developed Markets ETF) have nearly the same top holdings — their top 25 positions are about 91% the same by weight.
IDEV is cheaper at 0.04% vs 0.07% — a difference of $3.00 a year per $10,000 invested.
Over five years, IDEV returned +5.0% a year vs +4.5% for IEFA.
Updated Nov 19, 2026
IEFA vs IDEV side by side
| IEFA | IDEV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.07% | 0.04% |
| Annual cost per $10k | $7 | $4 |
| 10-yr cost on $10k (prospectus) | $90 | $51 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +3.4% | +4.5% |
| 5-yr return (annualized) | +4.5% | +5.0% |
| 10-yr return (annualized) | +5.4% | — |
| Best quarter | +18.0% | +16.9% |
| Worst quarter | −23.5% | −24.0% |
| Net assets (fund) | $190.1B | $31.6B |
| Number of holdings | 2,632 | 2,337 |
| Portfolio turnover | 3% | 3% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IEFA | IDEV | Difference |
|---|---|---|---|
| 2024 | +3.4% | +4.5% | −1.1% |
| 2023 | +17.6% | +17.3% | +0.4% |
| 2022 | −15.1% | −14.9% | −0.2% |
| 2021 | +11.3% | +12.7% | −1.4% |
| 2020 | +8.6% | +8.4% | +0.1% |
| 2019 | +22.7% | +23.4% | −0.7% |
| 2018 | −14.2% | −14.3% | +0.1% |
Source: Fund prospectus bar charts
Holdings overlap
23 of IEFA's top 25 holdings also appear in IDEV's top 25.
| Holding | IEFA | IDEV |
|---|---|---|
| ASML Holding N.V. | 2.50% | 2.19% |
| Hsbc Holdings Plc | 1.42% | 1.24% |
| Roche Holding AG | 1.20% | 1.05% |
| Novartis AG | 1.12% | 0.98% |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 1.02% | 1.16% |
| Nestle S.A. | 1.00% | 0.88% |
| Astrazeneca Plc | 1.00% | 0.88% |
| Shell Plc | 1.00% | 0.88% |
| Siemens Aktiengesellschaft | 0.95% | 0.83% |
| Mitsubishi UFJ Financial Group, Inc. | 0.93% | 0.82% |
| Bhp Group Limited | 0.83% | 0.73% |
| Commonwealth Bank Of Australia | 0.82% | 0.72% |
| Banco Santander, S.A. | 0.79% | 0.70% |
| Sap Se | 0.74% | 0.65% |
| Allianz SE | 0.74% | 0.65% |
Source: SEC Form N-PORT
IEFA top 10
- ASML Holding N.V. — 2.50%
- Hsbc Holdings Plc — 1.42%
- Roche Holding AG — 1.20%
- Novartis AG — 1.12%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.02%
- Nestle S.A. — 1.00%
- Astrazeneca Plc — 1.00%
- Shell Plc — 1.00%
- Siemens Aktiengesellschaft — 0.95%
- Mitsubishi UFJ Financial Group, Inc. — 0.93%
IDEV top 10
- ASML Holding N.V. — 2.19%
- Hsbc Holdings Plc — 1.24%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
- Roche Holding AG — 1.05%
- Royal Bank Of Canada — 1.00%
- Novartis AG — 0.98%
- Astrazeneca Plc — 0.88%
- Nestle S.A. — 0.88%
- Shell Plc — 0.88%
- Siemens Aktiengesellschaft — 0.83%
FAQ
What is the difference between IEFA and IDEV?
Which is cheaper, IEFA or IDEV?
Should I own both IEFA and IDEV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.